Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease.
Saved in:
| Title: | Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease. |
|---|---|
| Authors: | Tisdale RL; VA Palo Alto Health Care System (152-MPD), Health Services Research and Development (HSR&D), Center for Innovation to Implementation (Ci2i), 795 Willow Road, Building 324, Menlo Park, CA, 94025, USA. rtisdale@stanford.edu.; Department of Health Policy, School of Medicine, and Center for Health Policy, Freeman Spogli Institute for International Studies, Stanford University, Stanford, CA, USA. rtisdale@stanford.edu., Cusick MM; Department of Health Policy, School of Medicine, and Center for Health Policy, Freeman Spogli Institute for International Studies, Stanford University, Stanford, CA, USA., Aluri KZ; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA.; Stanford University School of Medicine, Stanford, CA, USA., Handley TJ; Department of Health Policy, School of Medicine, and Center for Health Policy, Freeman Spogli Institute for International Studies, Stanford University, Stanford, CA, USA.; Department of Surgery and Cancer, Imperial College London, London, UK.; Stanford-Surgery Policy Improvement Research & Education (S-SPIRE) Center, Stanford, CA, USA., Joyner AKC; Department of Management Science and Engineering, Stanford University, Stanford, CA, USA., Salomon JA; Department of Health Policy, School of Medicine, and Center for Health Policy, Freeman Spogli Institute for International Studies, Stanford University, Stanford, CA, USA., Chertow GM; Department of Health Policy, School of Medicine, and Center for Health Policy, Freeman Spogli Institute for International Studies, Stanford University, Stanford, CA, USA.; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA.; Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Goldhaber-Fiebert JD; Department of Health Policy, School of Medicine, and Center for Health Policy, Freeman Spogli Institute for International Studies, Stanford University, Stanford, CA, USA., Owens DK; Department of Health Policy, School of Medicine, and Center for Health Policy, Freeman Spogli Institute for International Studies, Stanford University, Stanford, CA, USA. |
| Source: | Journal of general internal medicine [J Gen Intern Med] 2022 Oct; Vol. 37 (13), pp. 3380-3387. Date of Electronic Publication: 2022 Feb 08. |
| Publication Type: | Journal Article; Research Support, U.S. Gov't, P.H.S.; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 8605834 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1497 (Electronic) Linking ISSN: 08848734 NLM ISO Abbreviation: J Gen Intern Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
